Benjamin Paluch

Stock Analyst at Roth MKM

(1.37)

# 2,532

Out of 4,667 analysts

3

Total ratings

66.67%

Success rate

4.82%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$32.24	+101.61%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$11.23	+51.38%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.49	+301.61%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $32.24

Upside: +101.61%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $11.23

Upside: +51.38%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.49

Upside: +301.61%